When considering a diagnosis of attention-deficit/hyperactivity disorder (ADHD), here are 9 symptoms of inattention to remember.
FDA expands label for lipid injectable emulsion to preterm and term neonates
Approximately 40% of patients who receive PN in the United States as an intravenous source of nourishment are under 18 years of age.
Food Insecurity and the Dangers of Infant Formula Dilution
Study lays groundwork for potential vaccine customized for children with recurrent eczema flares
These data from investigators at Trinity College Dublin highlighted the immune response mechanisms visible in children with atopic dermatitis.
Demystifying Infant Formula
Iron supplements ineffective at improving psychomotor development in breastfed babies
“We found no statistically significant effect of early iron supplementation on developmental scores at 24 and 36 months,” wrote the study investigators.
FDA accepts sBLA for dupilumab to treat CRSwNP in patients aged 12 to 17 years
The federal agency has accepted the sBLA for Priority Review designation, with a target action date of September 15, 2024.